|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | ||||||||||||||||||||
| Due from affiliate | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES & STOCKHOLDERS' DEFICIT | ||||||||||||||||||||
| Current Liabilities: | ||||||||||||||||||||
| Accrued expenses - stockholders and officers | ||||||||||||||||||||
| Accrued expenses - other | ||||||||||||||||||||
| Operating lease liabilities - current | ||||||||||||||||||||
| Due to affiliate | ||||||||||||||||||||
| Deposit on stock purchase | ||||||||||||||||||||
| Loans from stockholders and officers | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Stockholders' Deficit: | ||||||||||||||||||||
| Common Stock: authorized 100,000,000 shares of $0.001 par value;46,956,300 shares issued and outstanding | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders' deficit | ||||||||||||||||||||
| Total Liabilities and Stockholders' Deficit |
Loading...
